1Department of Nuclear Medicine, Taipei Veterans General Hospital, Taiwan
2National Yang-Ming University School of Medicine, Taiwan;National Defense Medical Center, Taipei, Taiwan
American Journal of Medical Case Reports.
2015,
Vol. 3 No. 5, 130-132
DOI: 10.12691/ajmcr-3-5-3
Copyright © 2015 Science and Education PublishingCite this paper: Tse-Hao Lee, Rong-Hsin Yang, Yum-Kung Chu. Rheumatoid Arthritis: An Exceptional Complication of Chemotherapy in a Patient with Lung Cancer.
American Journal of Medical Case Reports. 2015; 3(5):130-132. doi: 10.12691/ajmcr-3-5-3.
Correspondence to: Yum-Kung Chu, Department of Nuclear Medicine, Taipei Veterans General Hospital, Taiwan. Email:
ykchu@vghtpe.gov.twAbstract
A 63-year-old non-smoker, without previous history of arthritis, developed inflammatory arthritis while being treated with pemetrexed/cisplatin combination for advanced lung cancer. Clinical features and serology fulfilled the 2010 ACR/EULAR criteria for the diagnosis of rheumatoid arthritis (RA). RA is an autoimmune disease that primarily attacks joint tissues, causing inflammation of the joint lining. Although the relationship between these anticancer agents and the presence of RA remains unclear, this unprecedented adverse effect can be corrected by changing therapeutic strategies. Our case report might open a medical debate about chemotherapy side effect in cancer patients.
Keywords